Curaleaf Holdings, Inc.

TSX:CURA Stok Raporu

Piyasa değeri: CA$2.2b

Curaleaf Holdings Yönetim

Yönetim kriter kontrolleri 2/4

Curaleaf Holdings CEO'su Boris Jordan, Aug2024 tarihinde atandı, in görev süresi bir yıldan az. in toplam yıllık tazminatı $ 12.35M olup, şirket hissesi ve opsiyonları dahil olmak üzere 6.1% maaş ve 93.9% ikramiyelerden oluşmaktadır. şirketin hisselerinin 17.37% ine doğrudan sahiptir ve bu hisseler CA$ 384.10M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 2.3 yıl ve 5.4 yıldır.

Anahtar bilgiler

Boris Jordan

İcra Kurulu Başkanı

US$12.4m

Toplam tazminat

CEO maaş yüzdesi6.1%
CEO görev süresiless than a year
CEO sahipliği17.4%
Yönetim ortalama görev süresi2.3yrs
Yönetim Kurulu ortalama görev süresi5.4yrs

Son yönetim güncellemeleri

Recent updates

Investors Give Curaleaf Holdings, Inc. (TSE:CURA) Shares A 27% Hiding

Nov 09
Investors Give Curaleaf Holdings, Inc. (TSE:CURA) Shares A 27% Hiding

Curaleaf Holdings, Inc. (TSE:CURA) Shares Slammed 25% But Getting In Cheap Might Be Difficult Regardless

Aug 13
Curaleaf Holdings, Inc. (TSE:CURA) Shares Slammed 25% But Getting In Cheap Might Be Difficult Regardless

These 4 Measures Indicate That Curaleaf Holdings (TSE:CURA) Is Using Debt Extensively

Jul 19
These 4 Measures Indicate That Curaleaf Holdings (TSE:CURA) Is Using Debt Extensively

Some Confidence Is Lacking In Curaleaf Holdings, Inc. (TSE:CURA) As Shares Slide 27%

Jun 14
Some Confidence Is Lacking In Curaleaf Holdings, Inc. (TSE:CURA) As Shares Slide 27%

Subdued Growth No Barrier To Curaleaf Holdings, Inc. (TSE:CURA) With Shares Advancing 25%

Jan 19
Subdued Growth No Barrier To Curaleaf Holdings, Inc. (TSE:CURA) With Shares Advancing 25%

Does Curaleaf Holdings (CSE:CURA) Have A Healthy Balance Sheet?

Dec 11
Does Curaleaf Holdings (CSE:CURA) Have A Healthy Balance Sheet?

Is Curaleaf Holdings (CSE:CURA) Using Too Much Debt?

Sep 08
Is Curaleaf Holdings (CSE:CURA) Using Too Much Debt?

Curaleaf Holdings (CSE:CURA) Has Debt But No Earnings; Should You Worry?

May 28
Curaleaf Holdings (CSE:CURA) Has Debt But No Earnings; Should You Worry?

We Think Curaleaf Holdings (CSE:CURA) Is Taking Some Risk With Its Debt

Sep 05
We Think Curaleaf Holdings (CSE:CURA) Is Taking Some Risk With Its Debt

Here's Why Curaleaf Holdings (CSE:CURA) Has A Meaningful Debt Burden

May 20
Here's Why Curaleaf Holdings (CSE:CURA) Has A Meaningful Debt Burden

Is Curaleaf Holdings (CSE:CURA) A Risky Investment?

Oct 26
Is Curaleaf Holdings (CSE:CURA) A Risky Investment?

CEO Tazminat Analizi

Boris Jordan'un ücretlendirmesi Curaleaf Holdings'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Sep 30 2024n/an/a

-US$206m

Jun 30 2024n/an/a

-US$221m

Mar 31 2024n/an/a

-US$237m

Dec 31 2023US$12mUS$750k

-US$230m

Sep 30 2023n/an/a

-US$346m

Jun 30 2023n/an/a

-US$318m

Mar 31 2023n/an/a

-US$268m

Dec 31 2022US$3mUS$750k

-US$258m

Sep 30 2022n/an/a

-US$157m

Jun 30 2022n/an/a

-US$202m

Mar 31 2022n/an/a

-US$223m

Dec 31 2021US$3mUS$750k

-US$206m

Sep 30 2021n/an/a

-US$164m

Jun 30 2021n/an/a

-US$90m

Mar 31 2021n/an/a

-US$57m

Dec 31 2020US$2mUS$500k

-US$57m

Sep 30 2020n/an/a

-US$52m

Jun 30 2020n/an/a

-US$50m

Mar 31 2020n/an/a

-US$72m

Dec 31 2019US$750kUS$500k

-US$67m

Sep 30 2019n/an/a

-US$57m

Jun 30 2019n/an/a

-US$84m

Mar 31 2019n/an/a

-US$64m

Dec 31 2018US$2mUS$500k

-US$56m

Sep 30 2018n/an/a

-US$40m

Jun 30 2018n/an/a

-US$6m

Mar 31 2018n/an/a

-US$3m

Dec 31 2017US$94kn/a

-US$3m

Tazminat ve Piyasa: Boris 'nin toplam tazminatı ($USD 12.35M ), Canadian pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 2.06M ).

Tazminat ve Kazançlar: Boris şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.

CEO

Boris Jordan (58 yo)

less than a year

Görev süresi

US$12,352,753

Tazminat

Mr. Boris Alexis Jordan is Executive Chairman of the Board at Curaleaf, Inc. and serves as its CEO since 2024. He is Owner and Chief Investment Officer of Closed End Strategies of Measure 8 Ventures Manage...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Boris Jordan
CEO & Chairmanless than a yearUS$12.35m17.37%
CA$ 384.1m
Joseph Lusardi
Executive Vice-Chairman6.1yrsUS$1.23m0.71%
CA$ 15.7m
Edward Kremer
Chief Financial Officer2.3yrsUS$2.76m0.033%
CA$ 727.6k
Peter Clateman
Chief Legal Officer4.7yrsUS$1.39m0.11%
CA$ 2.3m
Matthew Darin
Special Advisorless than a yearUS$5.18m0.57%
CA$ 12.7m
Camilo Lyon
Chief Investment Officer2.3yrsVeri yokVeri yok
Christine Taylor
Chief Accounting Officerless than a yearVeri yokVeri yok
Scott Baughman
Chief Technology Officerno dataVeri yokVeri yok
Jakob Feinstein
Manager of Investor Relationsno dataVeri yokVeri yok
James Shorris
Chief Compliance Officer4.7yrsVeri yokVeri yok
Kate Lynch
Executive Vice President of Marketing3.8yrsVeri yokVeri yok

2.3yrs

Ortalama Görev Süresi

56yo

Ortalama Yaş

Deneyimli Yönetim: CURA 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.3 yıldır).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Boris Jordan
CEO & Chairman6.1yrsUS$12.35m17.37%
CA$ 384.1m
Joseph Lusardi
Executive Vice-Chairman6.1yrsUS$1.23m0.71%
CA$ 15.7m
Mitchell Kahn
Director4.3yrsUS$250.00k0.046%
CA$ 1.0m
Peter Derby
Independent Director6.1yrsUS$350.00k0.075%
CA$ 1.7m
Karl Johansson
Independent Director6.1yrsUS$350.00k0.019%
CA$ 418.5k
Robert Schnoll
Member of the Medical Advisory Boardno dataVeri yokVeri yok
Jaswinder Grover
Independent Director4.8yrsUS$250.00k0.74%
CA$ 16.5m
Michelle Bodner
Director1.9yrsUS$250.00k0.039%
CA$ 865.1k
Shasheen Shah
Independent Director1.9yrsUS$250.00k0.0089%
CA$ 196.3k

5.4yrs

Ortalama Görev Süresi

60.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: CURA 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 5.4 yıldır).